average 0 5-1 0 cm taller and 0 5-1 '0 kg heavier than the others. However, these differences were not significant (t test) at different ages or when all ages were combined (Table) . 
Discussion
The results of the present studies agree with earlier observations in Jamaican children (Ashcroft et al., 1976) and in Jamaican adults (Ashcroft et al., 1969) that no significant differences exist between heights and weights of AS and AA subjects. The only longterm population study to compare the health of AS and AA subjects is one from Jamaica (Ashcroft and Desai, 1976) . Mortality and morbidity were similar in 119 AS adults and 856 AA adults followed up for 12 years. The evidence therefore suggests that, with the exception of rare vascular occlusive episodes which may occur in severe anoxia, the AS genotype is benign and is not associated with abnormalities of growth.
Summary
No consistent differences were found in mean heights and weights of 170 schoolchildren aged 6-12 years with the sickle cell trait and 1247 schoolchildren with normal haemoglobin living in Dominica and Jamaica.
We thank the staff of various institutions in Jamaica and Dominica who made this investigation possible.
References Ashcroft, M. T., and Desai, P. (1976) . Mortality and morbidity in Jamaican adults with sickle-cell trait and with normal haemoglobin followed-up for 12 years. Lancet, 2, 784-786. Ashcroft, M. T., Desai, P., Richardson, S. A., and Serjeant, G. R. (1976) . Growth, behaviour and educational achievement of Jamaican children with sickle cell trait. (Roberton and Tizard, 1975) , partly because of improved ventilation technique (Kirby et al., 1972; Reynolds, 1974) . The duration of mechanical ventilation may still be protracted, particularly in very low birthweight infants. The ventilator dependence of some of these infants seems to be owing to inadequate ventilatory effort and therefore treatment with xanthines, which have been used effectively in neonatal apnoea (Shannon et al., 1975) , might facilitate their weaning from mechanical ventilation. This report describes two very low birthweight infants with severe HMD who were weaned from mechanical ventilation using both continuous-flow intermittent mandatory ventilation (IMV) (Kirby et al., 1972) and oral theophylline.
Shwort reports 599
Case reports Case 1. An infant born after 28 weeks' gestation and weighing 1090 g developed severe clinical HMD and at 11 hours progressed from endotracheal continuouspositive airway pressure (CPAP) to continuous-flow IMV using a pressure-limited, time-cycled ventilator * (Campbell, 1976) . Arterial oxygen tension (Pao2) was greater than 50 mmHg (6650 Pa) in 25% inspired oxygen concentration by the 4th day, and normocarbia (Paco5 < 45 mmHg (5985 Pa)) on minimal IMV-peak pressure 20 cm H50, positive end-expiratory pressure 6 cm H50 and frequency 6 cycles/min-was achieved on the 7th day. He breathed on CPAP for at least one hour (maximum 31 hours) on 19 occasions from the 8th to the 11th day; Paco2 was greater than 50 mmHg on 7 of 14 determinations made after a CPAP interval. On 3 other occasions, apnoea and bradycardia developed within 30 minutes of beginning CPAP; after the last of these episodes, which occurred on the 11th day, the IMV rate had to be increased to 10 cycles/min to maintain normocarbia and avoid bradycardia associated with hypopnoea. Plasma electrolytes and glucose were normal, there was neither systemic infection nor clinical persistence of the ductus arteriosus, and the lungs were radiographically normal. Oral theophylline, 1-8 mg/kg every six hours, was begun on the 12th day; within 14 hours he tolerated an IMV rate of 6 cycles/min without apnoea, bradycardia, or hypercarbia, and within 27 hours he breathed on CPAP without arterial blood gas or clinical need for IMV. He was extubated on the 13th day. The Paco2 during the 24 hours before theophylline was begun (42 * 4 +1 1 35 (mean ± SD) mmHg, n = 10) was not significantly different from that during the 24 hours after (46 2 + 10 01, n = 8). Theophylline was ceased on the 17th day at a time when there was no respiratory distress and arterial blood gases were normal in room air. Within 36 hours of theophylline being ceased, the infant was tachypnoeic with retractions and 30% inspired 02 concentration was needed to maintain normoxaemia. Chest x-ray, which had previously been normal, showed 'hazy' lung fields, consistent with chronic pulmonary insufficiency of prematurity (Krauss et al., 1975; Bednarek and Roloff, 1976) . Paco, during the four days before theophylline was ceased (36 0 ± 4 56, n = 9) was significantly lower than that during the five days after (42 8 ± 6-08, n = 4) (Mann-WVhitney U test, P < 0 05). Plasma theophylline was not measured in this infant. Case 2. An infant born after 28 weeks' gestation and weighing 1170 g developed severe HMD and was begun on continuous-flow IMV at four hours. Pao2 was greater than 50 mmHg (6650 Pa) in 25% inspired 02 concentration by the 3rd day, and normocarbia on mimimal IMV-peak pressure 16 cm H20, positive end-expiratory pressure 5 cm H,O and frequency 6 cycles/min-was achieved on the 4th day. He breathed on CPAP for between one and two hours on five occasions on the 5th day; the Paco2 was less than 50 mmHg after each CPAP period but two periods terminated with apnoea and bradycardia. After the second of these episodes the IMV rate was increased to 12 cycles/min to avoid bradycardia with hypopnoea and maintain normocarbia. Plasma electrolytes and glucose were normal and neither systemic infection nor persistence of the ductus arteriosus was evident. Chest x-ray was abnormal, but the coarse reticular pattern present was not prominent. Oral theophylline, 2-0 mg/kg every six hours, was begun on the 5th day ( Figure) ; within 5 hours he tolerated one-hour intervals of CPAP without apnoea, bradycardia, or hypercarbia and within 22 hours he was weaned to CPAP without need of IMV. He was extubated on the 7th day. Paco, during the 24 hours before theophylline was begun and while on IMV (41 * 3 ± 4 v 07, n = 7) was significantly higher than that after (34 -2 3 3 62, n = 8; P < 0 * 005) (Figure) . Theophylline was ceased on the 13th day. Paco, during the five days before theophylline was ceased (33 8 ± 4 00, n = 11) was . significantly lower than that during the six days after (48 3 i 10 03, n = 6; P < 0 001) (Figure) .
He did not require a higher ambient 0, concentration and the chest x-ray was normal after theophylline was ceased. Plasma theophylline concentration on the 8th day was 17 Xug/dl. Discussion IMV (Kirby et al., 1972 )-augmentation of spontaneous ventilatory effort with a ventilator frequency sufficient to maintain normocarbia and prevention of CO2 rebreathing by continuous gas flow-allowed recognition of dependence on low ventilator rates without which the two infants in this report developed apnoea or hypopnoea and bradycardia or hypercarbia. The minimal IMV and supplemental 02 requirements to maintain normal arterial blood gases, and the normal or near normal chest x-rays suggested that the ventilator dependence of the infants was owing to inadequate ventilatory effort and not to pulmonary parenchymal disease. The relative ease with which they were weaned to CPAP and then extubated after treatment with theophylline supports this suggestion, since the drug is of proved value in the spontaneously breathing preterm neonate with apnoea (Shannon et al., 1975) .
The mechanism whereby xanthines exert their beneficial effect in neonatal apnoea is unknown, though they have been reported not to increase alveolar ventilation, since Paco2 was unaffected (Shannon et al., 1975; Bednarek and Roloff, 1976) . However, the fact that in both infants Paco2 was lower while they were receiving theophylline than after, and that in one infant Paco2 was higher before theophylline was given than after, suggests an increase in alveolar ventilation during treatment with theophylline. The development of chronic pulmonary insufficiency of prematurity (Krauss et al., 1975) after theophylline was omitted in one infant also suggests that theophylline may have an effect on alveolar ventilation, since the condition is characterised by low lung volume and ventilation/ perfusion unevenness (Auld, 1975) When very low birthweight infants recovering from HMD are dependent on slow-rate IMV without which they develop apnoea or hypopnoea and/or hypercarbia, treatment with theophylline may facilitate weaning from mechanical ventilation.
Summary
Two very low birthweight infants with severe clinical hyaline membrane disease requiring mechanical ventilation were dependent on slow-rate intermittent mandatory ventilation, without which they developed apnoea or hypopnoea and hypercarbia. Their ventilator dependence was apparently owing to inadequate ventilatory effort, and treatment with oral theophylline allowed easy weaning to continuous-positive airway pressure and extubation. Paco2 was significantly lower during theophylline treatment, suggesting that the drug may have improved alveolar ventilation. 
